Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-05-07Clinical Trial Update: Taselisib and Enzalutamide in Treating Patients With Androgen Receptor Positive Triple-Negative Metastatic Breast Cancer [Phase 1, Phase 2]
Clinical trial update for taselisib plus enzalutamide in androgen receptor positive triple-negative metastatic breast cancer; trial phases 1…
-
CLINICAL_TRIALS trial_result · 2020-05-04Clinical Trial Update: Study of Single Agent Pembrolizumab (MK-3475) Versus Single Agent Chemotherapy for Metastatic Triple Negative Breast Cancer (MK-3475-119/KEYNOTE-119) [Phase 3]
Phase 3 trial comparing single-agent pembrolizumab to single-agent chemotherapy in metastatic triple-negative breast cancer has completed wi…
-
CLINICAL_TRIALS trial_result · 2020-05-04Clinical Trial Update: Study to Evaluate the Safety and Tolerability of Andecaliximab as Monotherapy and in Combination With Chemotherapy in Participants With Advanced Solid Tumors [Phase 1]
Phase 1 trial evaluating safety and tolerability of Andecaliximab as monotherapy and in combination with chemotherapy in advanced solid tumo…
-
CLINICAL_TRIALS trial_result · 2020-04-29Clinical Trial Update: TACTIC - TAA Specific Cytotoxic T Lymphocytes in Patients With Breast Cancer [Phase 2]
Phase 2 study evaluating TACTIC using TAA-specific cytotoxic T lymphocytes in breast cancer has completed, with results posted on 2020-04-29…
-
CLINICAL_TRIALS trial_result · 2020-04-29Clinical Trial Update: Combination Chemotherapy in Treating Patients With Breast Cancer [Phase 3]
A Phase 3 clinical trial evaluating combination chemotherapy in treating breast cancer has completed recruitment and results; the update ind…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-04-29Clinical Trial Update: Lymph Node Removal in Treating Women Who Have Stage I or Stage IIA Breast Cancer [Phase 3]
A Phase 3 clinical trial evaluating lymph node removal in women with Stage I or Stage IIA breast cancer has been completed.
-
FDA approval · 2020-04-27FDA Approved: CAPECITABINE — Original Application (Lifestar Pharma LLC)
FDA approves the original application for a generic capecitabine tablet by Lifestar Pharma LLC. This marks the availability of a generic ver…
-
CLINICAL_TRIALS trial_result · 2020-04-24Clinical Trial Update: Study Comparing Paclitaxel Plus Carboplatin Versus Anthracyclines Followed by Docetaxel as Adjuvant Chemotherapy for Triple Negative Breast Cancer (PATTERN) [Phase 3]
A Phase 3 trial comparing paclitaxel plus carboplatin versus anthracyclines followed by docetaxel as adjuvant chemotherapy for triple negati…
-
CLINICAL_TRIALS trial_result · 2020-04-22Clinical Trial Update: Predictors of Ovarian Insufficiency in Young Breast Cancer Patients
A completed clinical trial investigating predictors of ovarian insufficiency in young breast cancer patients, with results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-04-21Clinical Trial Update: A Study of TQ-B3525 Tablets Combined With Fulvestrant Injection in Subjects With HR-positive, HER2-negative and PIK3CA Mutation Advanced Breast Cancer [Phase 1, Phase 2]
A clinical trial update on TQ-B3525 tablets combined with fulvestrant for HR-positive, HER2-negative, PIK3CA-mutant advanced breast cancer (…
-
CLINICAL_TRIALS research · 2020-04-20Clinical Trial Update: Reproductive Health Survivorship Care Plan [NA]
Clinical trial update on a reproductive health survivorship care plan for breast cancer patients, with results posted after completion.
-
CLINICAL_TRIALS trial_result · 2020-04-20Clinical Trial Update: Combined MRI and Optical Imaging to Improved Breast Cancer Diagnosis [NA]
A terminated clinical trial investigating the combination of MRI and optical imaging to improve breast cancer diagnosis.
-
CLINICAL_TRIALS trial_result · 2020-04-20Clinical Trial Update: Reproductive Health Survivorship Care Plan Pilot [NA]
Pilot study update on a survivorship care plan for reproductive health in breast cancer patients, with results posted after completion.
-
CLINICAL_TRIALS trial_result · 2020-04-20Clinical Trial Update: High Risk ER+HER2- T1-2N0-1 Early Breast Cancer With Palbociclib Plus Endocrine Therapy(HIPEx) [Phase 2]
Phase 2 trial update for high-risk ER+/HER2- early breast cancer evaluating palbociclib plus endocrine therapy (HIPEx).
-
FDA approval · 2020-04-17FDA Approved: TUKYSA — Original Application (SEAGEN INC.)
FDA approves TUKYSA (tucatinib) in an original application for adults with HER2-positive metastatic breast cancer, including those with brai…
-
CLINICAL_TRIALS trial_result · 2020-04-15Clinical Trial Update: A Study to Assess the Safety and the Efficacy of IV Fosnetupitant/Palonosetron (260 mg/0.25 mg) Combination Compared to Oral Netupitant/Palonosetron (300 mg/0.5 mg) Combination for the Prevention of CINV in AC Chemotherapy in Women With Breast Cancer [Phase 3]
Phase 3 trial comparing IV fosnetupitant/palonosetron to oral netupitant/palonosetron for prevention of chemotherapy-induced nausea and vomi…
-
CLINICAL_TRIALS trial_result · 2020-04-14Clinical Trial Update: Anesthesia and Circulating Tumor Cells in Breast Cancer [Phase 4]
Phase 4 clinical trial update investigating anesthesia and circulating tumor cells in female breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2020-04-14Clinical Trial Update: Traditional Chinese Medicine as Preventive Method for Osteoporosis Induced by Adjuvant Endocrine Therapy [Phase 2]
Phase 2 clinical trial evaluating Traditional Chinese Medicine as a preventive method for osteoporosis induced by adjuvant endocrine therapy…
-
FDA approval · 2020-04-13FDA Approved: EXEMESTANE — Original Application (Florida Pharmaceutical Products, LLC)
FDA approved Florida Pharmaceutical Products, LLC's original application for Exemestane, a generic version of exemestane (Aromasin). The pro…
-
CLINICAL_TRIALS trial_result · 2020-04-13Clinical Trial Update: Trastuzumab, Cyclophosphamide, and an Allogeneic GM-CSF-secreting Breast Tumor Vaccine for the Treatment of HER-2/Neu-Overexpressing Metastatic Breast Cancer [Phase 2]
Phase 2 trial evaluating trastuzumab, cyclophosphamide, and an allogeneic GM-CSF-secreting breast tumor vaccine in HER-2/neu-overexpressing …
-
CLINICAL_TRIALS trial_result · 2020-04-10Clinical Trial Update: DC Vaccine for Patients With Ductal Carcinoma In Situ [Phase 1, Phase 2]
A Phase 1/2 clinical trial update for a dendritic cell vaccine targeting ductal carcinoma in situ (DCIS) within breast cancer.
-
CLINICAL_TRIALS trial_result · 2020-04-10Clinical Trial Update: Efficacy of Digital Breast Tomosynthesis + Standard 2- Dimensional Mammography in Breast Cancer [NA]
Completed trial evaluating efficacy of digital breast tomosynthesis added to standard 2D mammography for breast cancer detection.
-
CLINICAL_TRIALS trial_result · 2020-04-09Clinical Trial Update: Bevacizumab and Abraxane as Second-line Therapy in Triple Negative Metastatic Breast Cancer [Phase 2]
Phase 2 clinical trial evaluating bevacizumab and Abraxane as second-line therapy for metastatic triple-negative breast cancer has completed…
-
CLINICAL_TRIALS trial_result · 2020-04-08Clinical Trial Update: Anti-HER2 Therapy + Fulvestrant/Capecitabine in Women With HR+, HER2+, Non-visceral Metastases Stage IV Breast Cancer [Phase 3]
Phase 3 trial investigating anti-HER2 therapy combined with fulvestrant/capecitabine for HR+, HER2+, non-visceral metastatic breast cancer; …
-
CLINICAL_TRIALS trial_result · 2020-04-07Clinical Trial Update: Study in Post-menopausal Women With Hormone Receptor Positive, HER2-negative Advanced Breast Cancer [Phase 3]
Phase 3 trial update for postmenopausal women with hormone receptor positive, HER2-negative advanced breast cancer.